CDC25B and early-onset autosomal dominant Alzheimer disease: In Alzheimer’s disease, CDC25B activity increases the abnormal expression of Cdc2/cyclin B, resulting in various downstream indicators of mitotic events and eventually leading to neurodegeneration (Vincent et al., 2001).